Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia

Donor lymphocyte infusion (DLI) is commonly used to treat leukemia relapse following stem cell transplantation. In florid relapse, however, the efficacy of DLI is limited with substantial risk of severe graft-versus-host disease (GvHD). Here, we develop a novel risk-adapted strategy characterized by...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Rujkijyanont, P, Morris, C, Kang, G, Gan, K, Hartford, C, Triplett, B, Dallas, M, Srinivasan, A, Shook, D, Pillai, A, Pui, C-H, Leung, W
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2013
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3763390/
https://ncbi.nlm.nih.gov/pubmed/23995046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2013.39
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia